VIVO - Meridian Bioscience, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue200,771196,082194,830
Cost of Revenue75,93868,29572,948
Gross Profit124,833127,787121,882
Operating Expenses
Research Development15,68013,81512,605
Selling General and Administrative65,14361,11353,217
Non Recurring6,6281,4811,481
Total Operating Expenses---
Operating Income or Loss37,38251,37856,060
Income from Continuing Operations
Total Other Income/Expenses Net689163-997
Earnings Before Interest and Taxes38,07151,54155,063
Interest Expense1,642897897
Income Before Tax36,42950,64455,063
Income Tax Expense14,87218,41519,523
Minority Interest---
Net Income From Continuing Ops21,55732,22935,540
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income21,55732,22935,540
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares21,55732,22935,540